By expenditures
| Name | Title | Type |
|---|---|---|
| Eric Highlander | Business Manager | Auditee |
| Cindy Reilly | BUSINESS MANAGER | Auditee |
| Joseph Peterson | PARTNER | Auditee |
| Greg Pitel | Shareholder | Auditee |
| Carmen O'Brien | Chief Financial Officer | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 381833 | 2025 | 2026-01-15 | KERBERROSE S C | $2.13M |
| 348902 | 2024 | 2025-03-27 | Kerberrose Sc | $3.30M |
| 7273 | 2023 | 2023-12-18 | Miller Brussell Ebben & Glaeske LLC | $3.40M |
| 35309 | 2022 | 2022-12-27 | Miller Brussell Ebben and Glaeske Llcmiller Brus | $3.11M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 381833 | 2025 | 2026-01-15 | 1169087 | 2025-007 | Material Weakness | Yes | AB |
| 7273 | 2023 | 2023-12-18 | 581962 | 2023-003 | Significant Deficiency | - | P |
| 7273 | 2023 | 2023-12-18 | 581961 | 2023-002 | Significant Deficiency | - | P |
| 7273 | 2023 | 2023-12-18 | 581960 | 2023-003 | Significant Deficiency | - | P |
| 7273 | 2023 | 2023-12-18 | 581959 | 2023-002 | Significant Deficiency | - | P |
| 7273 | 2023 | 2023-12-18 | 5520 | 2023-003 | Significant Deficiency | - | P |
| 7273 | 2023 | 2023-12-18 | 5519 | 2023-002 | Significant Deficiency | - | P |
| 7273 | 2023 | 2023-12-18 | 5518 | 2023-003 | Significant Deficiency | - | P |
| 7273 | 2023 | 2023-12-18 | 5517 | 2023-002 | Significant Deficiency | - | P |